BioSolveIT (@biosolveit) 's Twitter Profile
BioSolveIT

@biosolveit

ID: 1314525222

linkhttp://www.biosolveit.com calendar_today29-03-2013 17:21:37

754 Tweet

645 Followers

212 Following

BioSolveIT (@biosolveit) 's Twitter Profile Photo

Tovorafenib received an FDA approval a few weeks ago and is now the star of this week's 'Gaze into Chemical Space'. #compchem #medchem #drugdiscovery #drugdesign #virtualscreening #CADD #ChemicalSpace

Tovorafenib received an FDA approval a few weeks ago and is now the star of this week's 'Gaze into Chemical Space'.

#compchem #medchem #drugdiscovery #drugdesign #virtualscreening #CADD #ChemicalSpace
BioSolveIT (@biosolveit) 's Twitter Profile Photo

Gazing at ML-193, a GPR55 antagonist: This GPCR ligand displays nanomolar inhibition with an improved selectivity profile over other related receptors. Furthermore, a total of three Chemical Spaces feature ML-193 as an exact match, among other relevant compounds in the remaining.

Gazing at ML-193, a GPR55 antagonist: This GPCR ligand displays nanomolar inhibition with an improved selectivity profile over other related receptors. Furthermore, a total of three Chemical Spaces feature ML-193 as an exact match, among other relevant compounds in the remaining.
BioSolveIT (@biosolveit) 's Twitter Profile Photo

The most sophisticated covalent docking out there features convenient transformation of 36 most commonly used warheads in drug discovery. Read more about the covered warheads, handling of stereochemistry and available customization 🔻 biosolveit.de/2024/06/20/cov… #compchem #medchem

BioSolveIT (@biosolveit) 's Twitter Profile Photo

Here is your quick rundown on the just-released infiniSee 6.1 update: 🟦 R group search in the Motif Matcher 🟦 Generation of ad hoc libraries 🟦 Support of semi-metals (Ge, As, Sb, Te) 🟦 Distinct similarity columns in the Analyzer Mode 🟦 And many more biosolveit.de/2024/06/24/r-g…

BioSolveIT (@biosolveit) 's Twitter Profile Photo

Our next webinar highlights the new features of the most recent release of the drug discovery software platforms SeeSAR and infiniSee. We will talk about sophisticated covalent docking, Chemical Space exploration and much more. July 11 4pm Berlin Time biosolveit.de/webinar/new-fe…

BioSolveIT (@biosolveit) 's Twitter Profile Photo

The increasing interest in designing drugs that covalently bind to their target can hardly be neglected. This spreadsheet features 36 of the most common covalent warheads used in medicinal chemistry as well as their bound form after transformation. SeeSAR: biosolveit.de/download/?prod…

The increasing interest in designing drugs that covalently bind to their target can hardly be neglected. This spreadsheet features 36 of the most common covalent warheads used in medicinal chemistry as well as their bound form after transformation.
SeeSAR: biosolveit.de/download/?prod…
BioSolveIT (@biosolveit) 's Twitter Profile Photo

‼️ Important announcement: The beta testing stage for Chemical Space Docking ends August 31st, 2024 ‼️ Chemical Space Docking allows you to perform efficient, in-house hit candidate assessment of billions or even trillions on your own hardware. biosolveit.de/2024/07/19/dea…

BioSolveIT (@biosolveit) 's Twitter Profile Photo

New guest, new challenge: Episode #2 of "What The Drug!?" is coming up! Let's see how much we can achieve this time and leap into yet maybe unexplored drug discovery areas. Save-the-date: Wed, 14 Aug 2024, 16:00 CEST (Berlin) Register following the link 🔻 biosolveit.de/webinar/drug-d…

BioSolveIT (@biosolveit) 's Twitter Profile Photo

We have an exclusive launch offer to share! No commitment, no strings attached. Just pure, unfiltered access to trillions of compounds for 3 Months! Don't miss out on this limited-time opportunity! ⌛ biosolveit.de/2024/08/27/inf…